GLP-1 CME Virtual Conference
- Mar. 3 – 5, 2027 (Wed–Fri)
- Online
- 20 Credits
- Member$915
- Non-Member$1125
- New Physician$865
- Student$715
- Resident$715
- Other$915
Purchases may be subject to applicable sales tax.
Final credit amount pending. Minimum 20 credits.
Early Bird Pricing: Register by February 20, 2027, to save $100.
GLP-1 therapies are increasingly central to primary care, with expanding uses across obesity, diabetes and cardiometabolic disease. In this three-day virtual conference livestream event, you’ll expand your knowledge beyond awareness and into confident, real-world application.
Dive into the latest in guideline updates. Learn when and why to prescribe GLP-1s to different types of patients. And sharpen your communication and longitudinal management skills with the growth of direct-to-consumer GLP-1 availability. This CME course features:
- Live Q&A: Get your questions answered by our expert faculty.
- Case-based discussion: Move beyond theory to patient application scenarios.
- Workflow-ready strategies: Improve your practice with better processes immediately.
- Interdisciplinary panel: Learn from a panel that includes family physicians, pharmacists, and patients.
GLP-1 therapies are increasingly central to primary care, with expanding uses across obesity, diabetes and cardiometabolic disease. In this three-day virtual conference livestream event, you’ll expand your knowledge beyond awareness and into confident, real-world application.
Dive into the latest in guideline updates. Learn when and why to prescribe GLP-1s to different types of patients. And sharpen your communication and longitudinal management skills with the growth of direct-to-consumer GLP-1 availability. This CME course features:
- Live Q&A: Get your questions answered by our expert faculty.
- Case-based discussion: Move beyond theory to patient application scenarios.
- Workflow-ready strategies: Improve your practice with better processes immediately.
- Interdisciplinary panel: Learn from a panel that includes family physicians, pharmacists, and patients.
Learning objectives
Apply evidence-based strategies to initiate, titrate, and adjust GLP‑1 therapies in real-world primary care settings.
Navigate access, coverage, and cost barriers by utilizing practical approaches to prior authorization, alternative therapies, and continuity planning.
Implement effective patient communication strategies to set expectations, address misinformation, and support adherence to long-term GLP‑1 therapy.
Develop longitudinal management plans that address maintenance, discontinuation, weight regain, and team-based care.
Evaluate safety considerations and risks associated with fragmented care, including telehealth and med spa prescribing, to ensure coordinated, physician-led management.
Schedule
Session 1: Session 1: Why GLP‑1s Matter Now
7:45–8:45 AM
Session 2: Understanding GLP-1s
8:45–9:45 AM
Session 3: Live Q&A
9:45–10:00 AM
Break
10:00–10:15 AM
Session 4: Starting GLP-1 Therapy in a 15-Minute Visit
10:15–11:15 AM
Session 5: Access and Coverage
11:15–12:15 PM
Session 6: Live Q&A
12:15–12:45 PM
Lunch
12:45–1:45 PM
Session 7: Patient Communication, Behavioral Health & Adherence
1:45–2:45 PM
Session 8: Managing patients ON therapy
2:45–3:45 PM
Session 9: Live Q&A
3:45–4:15 PM
Break
4:15-4:30 PM
Session 10: Real-World Panel Discussion
4:30–5:30 PM
Session 11: Safety & Controversies
7:45–8:45 AM
Session 12: Fragmentation, Telehealth, and Med Spas
8:45–9:45 AM
Session 13: Live Q&A
9:45–10:15 AM
Break
10:15–10:30 AM
Session 14: Expanded Indications & Emerging Uses
10:30–11:30 AM
Session 15: Future Therapies (Oral + Next-Gen)
11:30–12:30 PM
Session 16: Live Q&A
12:30–12:45 PM
Lunch
12:45–1:45 PM
Session 17: Life After GLP‑1s (OFF Therapy)
1:45–2:45 PM
Session 18: Putting It All Together: Clinical & Practice Integration
2:45–3:45 PM
Session 19: Final Live Q&A / Closing Discussion
3:45-4:15 PM
Session 20: Nutrition & Muscle Preservation
7:45–8:45
Session 21: GLP‑1s in Special Populations
8:45–9:45
Break
9:45–10:00 AM
Session 22: Health Equity & Access
10:00–11:00 AM
Session 23: Advanced Case Simulations
11:00 AM–12:00 PM
Session 24: Live Q&A
12:00–12:30 PM
Lunch
12:30–1:30 PM
Session 25: The Future of GLP‑1s in Primary Care
1:30–2:30 PM
Session 26: Final Program Q&A + Closing
2:30–3:00 PM